UK Researchers Launch Unbiased AI Testing Platform for Diabetic Retinopathy Screening

Researchers unveiled a new independent platform for fair, large-scale evaluation of commercial AI algorithms detecting diabetic eye disease within the NHS.
Key Details
- 1First real-world head-to-head platform to evaluate commercial AI algorithms for NHS use in detecting diabetic eye disease.
- 2Eight CE marked AI algorithms tested on 1.2 million retinal images from one of the UK’s largest and most diverse screening programs.
- 3Algorithm performance (accuracy) ranged from 83.7% to 98.7% for clinically relevant diabetic eye disease, outperforming or matching human graders.
- 4Algorithms’ accuracy remained consistent across varied ethnic groups; first such assessment at this scale.
- 5AI analyzed images in 240ms–45s compared to up to 20 minutes for humans, vastly improving efficiency.
- 6Funded by NHS Transformation Directorate, The Health Foundation, and Wellcome Trust; study published in The Lancet Digital Health.
Why It Matters

Source
EurekAlert
Related News

Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.

New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.

AI Analyzes 66,000 MRI Scans to Map Body Composition Risks
Researchers used AI to analyze over 66,000 whole-body MRI scans, creating a detailed body composition reference map linked to health risks.